ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenRepertoire Immune Medicines (Switzerland) AG
Repertoire Immune Medicines (Switzerland) AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Repertoire Immune Medicines (Switzerland) AG

Industry:
Research & Development
Pharmaceutical Industry
✓ Offered6
DECODE Platform
Suite of integrated experimental and computational technologies for analysing the immunological synapse system, identifying TCRs and disease-relevant epitopes across all human HLAs.
TCR-Bispecific Immune Medicines
Off-the-shelf TCR-bispecifics with a TCR, anti-CD3 module and a tumor-specific epitope; developed for solid and haematological cancers.
mRNA Cancer Vaccines
Off-the-shelf mRNA cancer vaccines with shared, highly immunogenic tumor-specific epitopes in lipid nanoparticles; under development for non-small cell lung cancer and colorectal cancer.
mRNA Tolerizing Vaccines
Off-the-shelf mRNA tolerizing vaccines with disease-relevant, tissue-specific epitopes and an immunomodulator; developed to restore immune homeostasis in autoimmune diseases.
Programmed immunotherapies for cancer
Targeted immune medicines for the treatment of solid and haematological tumours, including several programmed approaches for different cancer types.
Programmed immunotherapies for autoimmune diseases
Targeted immune medicines for the treatment of autoimmune diseases, aiming to specifically induce tolerance to disease-relevant immune responses and enable remission.
Trust & reputation

ranQ Trust Score of Repertoire Immune Medicines (Switzerland) AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Repertoire Immune Medicines (Switzerland) AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Repertoire Immune Medicines (Switzerland) AG scores 83.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Repertoire Immune Medicines (Switzerland) AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Repertoire Immune Medicines (Switzerland) AG scores 68.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.68.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Repertoire Immune Medicines (Switzerland) AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Repertoire Immune Medicines (Switzerland) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Repertoire Immune Medicines (Switzerland) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Repertoire Immune Medicines (Switzerland) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Repertoire Immune Medicines (Switzerland) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 27
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-153.467.041
Founded
2018 · 8 years
Last commercial register change
April 17, 2025
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    DL
    DAiNA Laboratories AG
    Schlieren
    LB
    LimmaTech Biologics AG
    Schlieren
    HA
    hemotune AG
    Schlieren
    AT
    Amicus Therapeutics Switzerland GmbH
    Zurich
    EA
    evitria AG
    Fahrweid
    FN
    Foundation National Institute for Cancer Epidemiology and Registration (NICER)
    Zurich
    LI
    Ludwig Institut für Krebsforschung AG
    Zurich
    EA
    EVIIVE AG
    Obfelden